内容

目次

Foreword Contributors Part I. Methodological and Technological Advances 1. Where do we stand in the quest for neuropsychiatric biomarkers and endophenotypes and what next? Michael S. Ritsner and Irving I. Gottesman 2. Methodological and statistical issues in the use of biomarkers in clinical and research studies. Ryan Van Lieshout and Peter Szatmari 3. Challenging the genetic complexity of schizophrenia by use of endophenotypes. Assen Jablensky 4. Translational medicine: functional biomarkers for drug development of 'cognitive enhancers' in schizophrenia. Georg Winterer 5. Leveraging high-dimensional neuroimaging data in genetic studies of neuropsychiatric disease. Cinnamon S. Bloss, Trygve E. Bakken, Alexander H. Joyner, Nicholas J. Schork 6. Proteomics as a new tool for biomarker-discovery in neuropsychiatric disorders. Thomas J. Raedler, Harald Mischak, Holger Jahn, Klaus Wiedemann 7. Schizophrenia endophenotypes as treatment targets. Stephen I. Deutsch, Barbara L. Schwartz, Richard B. Rosse, John Mastropaolo, Ayman H. Fanous, Abraham Weizman, Jessica A. Burket, Brooke L. Gaskins Part II. Neuropsychological, Neurocognitive and Neurophysiological Domains 8. Neuropsychological endophenotypes in schizophrenia and bipolar I disorder: yields from the Finnish family and twin studies. Annamari Tuulio-Henriksson, Jonna Perälä, Irving I. Gottesman and Jaana Suvisaari 9. Is more cognitive experimental psychopathology of schizophrenia really necessary? Challenges and opportunities. Angus MacDonald, III 10. Intellectual functioning as an endophenotype for schizophrenia. Odette de Wilde 11. Emotion recognition deficits as a neurocognitive marker of schizophrenia liability. Renata Schoeman, Dana J. H. Niehaus, Liezl Koen, Jukka M. Leppänen 12. The use of neurocognitiveendophenotypes in large-scale family genetic studies of schizophrenia. William P. Horan, Tiffany A. Greenwood, David L. Braff, Raquel E. Gur and Michael F. Green 13. Neurocognitive endophenotypes for bipolar disorder: evidence from case-control, family and twin studies. Eugenia Kravariti, Fergus Kane, Robin Murray 14. Trait and state markers of schizophrenia in visual processing. Yue Chen, Daniel Norton and Ryan McBain 15. Visual scanning abnormalities as biomarker for schizophrenia and bipolar disorder. Patricia E. G. Bestelmeyer 16. Biomarkers and endophenotypes in eating disorders. Carolina Lopez, Marion Roberts and Janet Treasure 17. Movement abnormalities: a putative biomarker of risk for psychosis. Vijay Mittal and Elaine Walker Afterword by Robert H. Belmaker Contents of Volumes 2, 3, and 4 Contributors of Volumes 2, 3, and 4 Index